IRRAS has an experienced management team with substantial collective experience developing medical devices and therapeutics, including significant operational, commercial, marketing and financial experience with medical device and emerging biotechnology companies.
Will Martin
President and CEO
CEO and President since 2021.
Education: B.A. in finance and computer applications from the University of Notre Dame and an MBA from Johns Hopkins University.
Other experience: Will Martin most recently served as General Manager of Peripheral Vascular (PV) Devices for Philips Healthcare. In this role, he oversaw the growth and expansion of Philips Healthcare into the PV interventional space and was responsible for defining and owning the global PV business strategy. During his tenure, the PV segment was one of the fastest growing businesses in Philips. Prior to Philips, Will Martin was Vice President of Commercial Operations and Vice President of Marketing and Business Development at AtheroMed, Inc. He served as Vice President of Sales and Marketing at Hotspur Technologies, Inc. and Vice President of International Sales at AccessClosure, Inc., and held other key commercial roles at Boston Scientific Corporation, Aventis Pharmaceuticals and Corning, Inc.
Other current assignments: Board member of Morris Innovative.
Previous assignments over the past five years: General Manager, Peripheral Vascular devices, Philips Healthcare.
Griffen Stapp
Chief Financial Officer
Chief Financial Officer since 2021.
Education: Griffen Stapp has a master’s degree in Business Administration with an emphasis in Accounting from Cal State University of San Marcos.
Other experience: Griffen Stapp is a former CPA who has extensive experience in the areas of internal controls, auditing, and business analytics.
Other current assignments: Board Member of California Communication Access Foundation and Wesley House. Advisory Board Member of Clear Blue Sea
Previous assignments over the past five years: From 2019 to 2021 Griffen Stapp was the Head of Finance for New Leaf Biofuel. From 2015 to 2019 Griffen Stapp was the CFO for Gaia Medical Biosciences.
Adam Sampson
Vice President of Product Excellence
Vice President of Product Excellence since 2018.
Education: Adam Sampson has a B.Sc. in Mechanical Engineering from San Diego State University and holds an extensive range of technical, business and management certifications.
Other experience: Adam Sampson is a global executive with strategic and tactical product leadership experience spanning the life sciences, high performance computing, construction and government contracting industries. He has made a career of developing profitable new products and strengthening core revenue streams with worldwide customers such as American Express, eBay, Kohler and Roca. He has been essential to the development, commercialization and sustaining of 14 new product platforms, all IP novel, of which nine were major profit-generating engines. Adam Sampson is a catalyst for continuous growth and improvement by integrating a customer focus with operational excellence and emerging technologies. He has optimized or created five entire product life cycle processes and is the inventor, or managed the inventors, behind over 30 issued patents plus numerous active patent applications.
Other current assignments: None.
Previous assignments over the past five years: Adam Sampson served as Global VP of Engineering & Product Development at Fluidmaster.
Kellie Fontes
Vice President, Human Capital
Vice President Human Capital since 2022, employed in 2018.
Education: B.Sc. in Speech Communication from Montana State University and a certificate in Human Resource Management from the University of California.
Other experience: Kellie Fontes is a results-oriented HR leader, recognized for her ability to build strong teams and lead in the creation of positive, passionate and dynamic company cultures. She has vast experience within the medical device, pharmaceutical and high-technology industries, bringing in-depth knowledge of all aspects of HR. She has led extensive coaching of Senior Leaders on building personal capabilities and execution of business strategy.
Other current assignments: Board President, San Diego HR Forum.
Previous assignments over the past five years: Kellie previously served as US Director, Employee Relations at GlaxoSmithKline and Director, Employee Relations and Compliance at General Atomics.
